Mosier DE - Search Results

1

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, Parren PW, Mosier DE, Burton DR. Poignard P, et al. Among authors: mosier de. Immunity. 1999 Apr;10(4):431-8. doi: 10.1016/s1074-7613(00)80043-6. Immunity. 1999. PMID: 10229186 Free article.

2

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

Parren PW, Ditzel HJ, Gulizia RJ, Binley JM, Barbas CF 3rd, Burton DR, Mosier DE. Parren PW, et al. Among authors: mosier de. AIDS. 1995 Jun;9(6):F1-6. doi: 10.1097/00002030-199506000-00001. AIDS. 1995. PMID: 7662189

3

The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.

Picchio GR, Gulizia RJ, Wehrly K, Chesebro B, Mosier DE. Picchio GR, et al. Among authors: mosier de. J Virol. 1998 Mar;72(3):2002-9. doi: 10.1128/JVI.72.3.2002-2009.1998. J Virol. 1998. PMID: 9499054 Free PMC article.

4

Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.

Mosier DE, Picchio GR, Gulizia RJ, Sabbe R, Poignard P, Picard L, Offord RE, Thompson DA, Wilken J. Mosier DE, et al. J Virol. 1999 May;73(5):3544-50. doi: 10.1128/JVI.73.5.3544-3550.1999. J Virol. 1999. PMID: 10196243 Free PMC article.

5

Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization.

Venturini S, Mosier DE, Burton DR, Poignard P. Venturini S, et al. Among authors: mosier de. J Virol. 2002 Jul;76(14):6987-99. doi: 10.1128/jvi.76.14.6987-6999.2002. J Virol. 2002. PMID: 12072499 Free PMC article.

6

Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.

Picchio GR, Nakatsuno M, Boggiano C, Sabbe R, Corti M, Daruich J, Pérez-Bianco R, Tezanos-Pinto M, Kokka R, Wilber J, Mosier D. Picchio GR, et al. J Med Virol. 1997 Jun;52(2):219-25. J Med Virol. 1997. PMID: 9179772

7

Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse model.

Mosier DE, Gulizia RJ, MacIsaac P, Mathieson BJ, Smith G, Hu SL, Corey L, Greenberg P. Mosier DE, et al. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1387. doi: 10.1089/aid.1992.8.1387. AIDS Res Hum Retroviruses. 1992. PMID: 1466962 No abstract available.

8

Human immunodeficiency virus infection of human-PBL-SCID mice.

Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA. Mosier DE, et al. Science. 1991 Feb 15;251(4995):791-4. doi: 10.1126/science.1990441. Science. 1991. PMID: 1990441

9

Transfer of a functional human immune system to mice with severe combined immunodeficiency.

Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Mosier DE, et al. Nature. 1988 Sep 15;335(6187):256-9. doi: 10.1038/335256a0. Nature. 1988. PMID: 2970594

10

Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism.

van Kuyk R, Torbett BE, Gulizia RJ, Leath S, Mosier DE, Koenig S. van Kuyk R, et al. Among authors: mosier de. J Immunol. 1994 Nov 15;153(10):4826-33. J Immunol. 1994. PMID: 7963548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters